Basal insulin


Basal insulin (also Long-term insulin or Basic insulin called) covers the body's continuous basic need for insulin - even at night and between meals. It simulates the natural basal secretion of the pancreas and ensures stable fasting blood sugar levels. Modern basal insulins are usually only injected once a day.

Mode of action

Basal insulin is released slowly and evenly from the subcutaneous fatty tissue. It inhibits the liver's glucose production and keeps blood sugar stable for many hours without sharp spikes. In contrast to bolus insulin (mealtime insulin), it does not affect food intake, but rather the basic requirement.

Important active ingredients and preparations (as of 2026)

active ingredient Brand names Duration of action Injection frequency
Insulin glargine U100 Lantus, Abasaglar approx. 24 hours 1× daily
Insulin glargine U300 Toujeo up to 36 hours 1× daily
Insulin degludec Tresiba up to 42 hours 1× daily (very flexible)
Insulin detemir Levemir 18-24 hours 1-2 times daily

Advantages

  • Stable blood sugar levels over 24 hours
  • Lower risk of hypoglycemia than older NPH insulins
  • More flexible injection times (especially Tresiba)
  • Fewer nighttime hypoglycaemia

Disadvantages and risks

  • Hypoglycemia possible if the dose is too high
  • Weight gain (typical of all insulins)
  • Lipohypertrophy in the absence of injection site rotation

Further information:
Diabetes mellitus – knowledge and overview
Why hyporest
Type 2 diabetes

Sources

  1. German Diabetes Society (DDG). S3 guideline “Type 2 diabetes”. As of 2025. Available at: www.deutsche-diabetes-gesellschaft.de/leitlinien.
  2. American Diabetes Association. Standards of Medical Care in Diabetes—2026. Diabetes Care. 2026;49(Suppl 1). Available at: diabetesjournals.org.
  3. Robert Koch Institute (RKI). Federal health reporting – diabetes mellitus in Germany. Berlin 2024.
  4. International Diabetes Federation (IDF). IDF Diabetes Atlas. 11th edition. Brussels 2025. Available at: diabetesatlas.org.

Important note:
The information in this encyclopedia article is intended solely for general and non-binding information. They do not replace medical advice, diagnosis or therapy. If you have any health questions or complaints, please always consult a doctor or qualified healthcare professional. The content was created with the greatest possible care, but errors cannot be completely ruled out.

Last updated: February 26, 2026


Unser Blog wird fachlich gegengelesen von Daniela MikaDiabetesberaterin (DDG)

Daniela Mika begleitet seit über 20 Jahren Menschen mit Diabetes, mit Schwerpunkt auf der Insulinpumpentherapie. Neben ihrer Arbeit am Krankenhaus in Lippstadt ist sie Referentin auf Fachveranstaltungen und setzt sich aktiv für Frauengesundheit bei Diabetes ein.